Luciferase siRNA administration in a subcutaneous tumor model.
AteloGeneR QG and AteloGeneR Local Use were mixed with Luciferase
siRNA (Luc siRNA) respectively, and evaluated for the luminescence of
Luciferase after administration in a Dual-luciferase expressed
subcutaneous tumor model.
Result with AteloGeneR QG showed higher inhibition of Luciferase gene
expression than results compared to AteloGeneR Local Use.
Increased number of administrations.